LV10749B - Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof - Google Patents
Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof Download PDFInfo
- Publication number
- LV10749B LV10749B LVP-93-1204A LV931204A LV10749B LV 10749 B LV10749 B LV 10749B LV 931204 A LV931204 A LV 931204A LV 10749 B LV10749 B LV 10749B
- Authority
- LV
- Latvia
- Prior art keywords
- die
- therapeutic system
- transdermal therapeutic
- der
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4238223A DE4238223C1 (de) | 1992-11-12 | 1992-11-12 | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10749A LV10749A (lv) | 1995-08-20 |
| LV10749B true LV10749B (en) | 1996-06-20 |
Family
ID=6472735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-1204A LV10749B (en) | 1992-11-12 | 1993-11-05 | Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5698216A (sv) |
| EP (1) | EP0667774B1 (sv) |
| JP (1) | JP3407073B2 (sv) |
| KR (1) | KR100254573B1 (sv) |
| CN (1) | CN1088457A (sv) |
| AT (1) | ATE156356T1 (sv) |
| AU (1) | AU684256B2 (sv) |
| CA (1) | CA2147274C (sv) |
| CZ (1) | CZ284008B6 (sv) |
| DE (2) | DE4238223C1 (sv) |
| DK (1) | DK0667774T3 (sv) |
| EE (1) | EE03135B1 (sv) |
| EG (1) | EG20527A (sv) |
| ES (1) | ES2105334T3 (sv) |
| FI (1) | FI952269A (sv) |
| GR (1) | GR3024720T3 (sv) |
| HR (1) | HRP931391B1 (sv) |
| HU (1) | HUT72963A (sv) |
| IL (1) | IL107547A (sv) |
| LT (1) | LT3107B (sv) |
| LV (1) | LV10749B (sv) |
| MD (1) | MD937C2 (sv) |
| MY (1) | MY111373A (sv) |
| NO (1) | NO306760B1 (sv) |
| NZ (1) | NZ257136A (sv) |
| PL (1) | PL172999B1 (sv) |
| RU (1) | RU2108812C1 (sv) |
| SI (1) | SI9300589A (sv) |
| SK (1) | SK280185B6 (sv) |
| WO (1) | WO1994010999A1 (sv) |
| YU (1) | YU71293A (sv) |
| ZA (1) | ZA938413B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4446600A1 (de) * | 1994-12-24 | 1996-06-27 | Lohmann Therapie Syst Lts | Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen |
| DE19828273B4 (de) * | 1998-06-25 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren |
| DE19923551A1 (de) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
| AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3921363A (en) | 1974-05-17 | 1975-11-25 | Preston Metal & Roofing Prod | Cross member with end connector |
| IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
| US4680172A (en) | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
| DE3843238C1 (sv) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| DE3843239C1 (sv) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| US5350581A (en) * | 1989-12-14 | 1994-09-27 | Pharmetrix Corporation | Method for manufacturing transdermal devices |
| NZ237241A (en) * | 1990-03-02 | 1993-11-25 | Pharmetrix Corp | Method for increasing the storage stability of physostigmine |
| WO1991015176A1 (en) * | 1990-04-06 | 1991-10-17 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
| JP4355469B2 (ja) * | 2002-03-08 | 2009-11-04 | 日本碍子株式会社 | アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法 |
-
1992
- 1992-11-12 DE DE4238223A patent/DE4238223C1/de not_active Expired - Lifetime
-
1993
- 1993-10-27 PL PL93308531A patent/PL172999B1/pl unknown
- 1993-10-27 NZ NZ257136A patent/NZ257136A/en unknown
- 1993-10-27 ES ES93923558T patent/ES2105334T3/es not_active Expired - Lifetime
- 1993-10-27 RU RU95113504A patent/RU2108812C1/ru active
- 1993-10-27 EP EP93923558A patent/EP0667774B1/de not_active Expired - Lifetime
- 1993-10-27 AU AU53385/94A patent/AU684256B2/en not_active Ceased
- 1993-10-27 US US08/433,459 patent/US5698216A/en not_active Expired - Lifetime
- 1993-10-27 JP JP51164994A patent/JP3407073B2/ja not_active Expired - Fee Related
- 1993-10-27 DE DE59307089T patent/DE59307089D1/de not_active Expired - Lifetime
- 1993-10-27 CZ CZ951244A patent/CZ284008B6/cs not_active IP Right Cessation
- 1993-10-27 WO PCT/EP1993/002970 patent/WO1994010999A1/de active IP Right Grant
- 1993-10-27 DK DK93923558.6T patent/DK0667774T3/da active
- 1993-10-27 AT AT93923558T patent/ATE156356T1/de active
- 1993-10-27 KR KR1019950701873A patent/KR100254573B1/ko not_active IP Right Cessation
- 1993-10-27 SK SK593-95A patent/SK280185B6/sk unknown
- 1993-10-27 HU HU9501390A patent/HUT72963A/hu unknown
- 1993-10-27 CA CA002147274A patent/CA2147274C/en not_active Expired - Fee Related
- 1993-11-05 LV LVP-93-1204A patent/LV10749B/lv unknown
- 1993-11-09 IL IL10754793A patent/IL107547A/en not_active IP Right Cessation
- 1993-11-10 YU YU71293A patent/YU71293A/sh unknown
- 1993-11-11 HR HRP4238223.8A patent/HRP931391B1/xx not_active IP Right Cessation
- 1993-11-11 MY MYPI93002363A patent/MY111373A/en unknown
- 1993-11-11 CN CN93112909A patent/CN1088457A/zh active Pending
- 1993-11-11 EG EG71993A patent/EG20527A/xx active
- 1993-11-11 SI SI9300589A patent/SI9300589A/sl unknown
- 1993-11-11 ZA ZA938413A patent/ZA938413B/xx unknown
- 1993-11-12 LT LTIP1469A patent/LT3107B/lt not_active IP Right Cessation
-
1994
- 1994-07-26 MD MD94-0311A patent/MD937C2/ro active IP Right Grant
- 1994-11-18 EE EE9400145A patent/EE03135B1/xx unknown
-
1995
- 1995-05-10 FI FI952269A patent/FI952269A/sv unknown
- 1995-05-11 NO NO951864A patent/NO306760B1/no not_active IP Right Cessation
-
1997
- 1997-09-16 GR GR970402363T patent/GR3024720T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4002281C2 (sv) | ||
| EP1077688B1 (de) | Transdermales therapeutisches system (tts) pergolid enthaltend | |
| DE19837902B4 (de) | Transdermalpflaster | |
| EP0680325B1 (de) | Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil | |
| EP0716599B1 (de) | TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR ABGABE VON 17-$g(b)-ESTRADIOL UND VERFAHREN ZU SEINER HERSTELLUNG | |
| DE69205010T2 (de) | Transdermales estradiol als therapeutisches system. | |
| DD290582A5 (de) | Verfahren zur herstellung eines transdermalen therapeutischen systems zur verabreichung von physostigmin an die haut | |
| EP0665745B1 (de) | Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung | |
| DE10012908B4 (de) | Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung | |
| DE10224612A1 (de) | Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung | |
| EP1372619B1 (de) | Verfahren zur herstellung eines hochflexiblen transdermalen therapeutischen systems mit nikotin als wirkstoff | |
| DE10137082A1 (de) | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol | |
| DE2741755C2 (de) | Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben | |
| EP1063983B1 (de) | Transdermales therapeutisches system (tts) oxybutynin enthaltend | |
| EP0781134B9 (de) | Scopolaminpflaster | |
| EP0584126B1 (de) | Lanolinderivate als penetrationsfördernde substanzen | |
| DE3880754T2 (de) | Perkutanes Präparat mit kontrollierter Abgabe. | |
| EP1152751B1 (de) | Desoxypeganin-tts | |
| LV10749B (en) | Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof | |
| EP0143857B1 (de) | Coronartherapeutikum in Form von Weichgelatine-Kapseln | |
| DE3902013A1 (de) | Pflaster zur transdermalen anwendung | |
| DE19738643A1 (de) | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase | |
| EP0456792B1 (de) | VERBESSERTES TRANSDERMALES SYSTEM ZUR APPLIKATION VON PHARMAKOLOGISCH AKTIVEN VERBINDUNGEN UNTER pH-KONTROLLIERTEN BEDINGUNGEN | |
| EP0559702B1 (de) | Retardzubereitung für urapidil | |
| DE4438989A1 (de) | Scopolaminpflaster |